1. Home
  2. BMRC vs IVA Comparison

BMRC vs IVA Comparison

Compare BMRC & IVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BMRC
  • IVA
  • Stock Information
  • Founded
  • BMRC 1989
  • IVA 2011
  • Country
  • BMRC United States
  • IVA France
  • Employees
  • BMRC N/A
  • IVA N/A
  • Industry
  • BMRC Major Banks
  • IVA Biotechnology: Pharmaceutical Preparations
  • Sector
  • BMRC Finance
  • IVA Health Care
  • Exchange
  • BMRC Nasdaq
  • IVA Nasdaq
  • Market Cap
  • BMRC 416.8M
  • IVA 359.6M
  • IPO Year
  • BMRC N/A
  • IVA 2020
  • Fundamental
  • Price
  • BMRC $23.78
  • IVA $2.97
  • Analyst Decision
  • BMRC Buy
  • IVA Strong Buy
  • Analyst Count
  • BMRC 4
  • IVA 4
  • Target Price
  • BMRC $25.50
  • IVA $10.50
  • AVG Volume (30 Days)
  • BMRC 117.4K
  • IVA 12.7K
  • Earning Date
  • BMRC 07-28-2025
  • IVA 03-26-2025
  • Dividend Yield
  • BMRC 4.25%
  • IVA N/A
  • EPS Growth
  • BMRC N/A
  • IVA N/A
  • EPS
  • BMRC N/A
  • IVA N/A
  • Revenue
  • BMRC $70,630,000.00
  • IVA $14,591,573.00
  • Revenue This Year
  • BMRC $60.39
  • IVA $15.38
  • Revenue Next Year
  • BMRC $10.56
  • IVA $24.22
  • P/E Ratio
  • BMRC N/A
  • IVA N/A
  • Revenue Growth
  • BMRC N/A
  • IVA N/A
  • 52 Week Low
  • BMRC $16.97
  • IVA $1.53
  • 52 Week High
  • BMRC $27.11
  • IVA $4.05
  • Technical
  • Relative Strength Index (RSI)
  • BMRC 45.68
  • IVA 38.99
  • Support Level
  • BMRC $24.57
  • IVA $3.12
  • Resistance Level
  • BMRC $25.40
  • IVA $3.61
  • Average True Range (ATR)
  • BMRC 0.62
  • IVA 0.24
  • MACD
  • BMRC -0.28
  • IVA -0.01
  • Stochastic Oscillator
  • BMRC 12.15
  • IVA 13.95

About BMRC Bank of Marin Bancorp

Bank of Marin Bancorp is a United States-based bank holding company. It conducts business through its wholly-owned subsidiary. The Bank provides a wide range of financial services to customers such as professionals, small and middle-market businesses, and individuals residing in Marin, Sonoma, Napa, San Francisco, Alameda, Contra Costa, San Mateo counties and others. The majority of its revenue comes from interest income.

About IVA Inventiva S.A. American Depository Shares

Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.

Share on Social Networks: